---
figid: PMC9597488__IID3-10-e721-g005
pmcid: PMC9597488
image_filename: IID3-10-e721-g005.jpg
figure_link: /pmc/articles/PMC9597488/figure/iid3721-fig-0001/
number: Figure 1
figure_title: ''
caption: 'Schematic of the experimental protocol. Nongenomic effect (rapid): usually
  occur within a few minutes via membrane‐bound receptors. Genomic effect (delayed
  and long‐lasting): usually take several hours or days to manifest specific gene
  transcription. Cane, potassium canrenoate; Dexa, dexamethasone; ED50, median effective
  dose; ELISA, enzyme‐linked immunosorbent assay; FCA, Freund''s complete adjuvant;
  IL‐6, interleukin 6; i.pl., intraplantar.'
article_title: Dexamethasone and potassium canrenoate alleviate hyperalgesia by competitively
  regulating IL‐6/JAK2/STAT3 signaling pathway during inflammatory pain in vivo and
  in vitro.
citation: Jie Liu, et al. Immun Inflamm Dis. 2022 Nov;10(11):e721.
year: '2022'

doi: 10.1002/iid3.721
journal_title: Immunity, Inflammation and Disease
journal_nlm_ta: Immun Inflamm Dis
publisher_name: John Wiley and Sons Inc.

keywords:
- dexamethasone
- IL‐6
- inflammatory pain
- potassium canrenoate

---
